CELH
Get informed when a big investor buys or sells
+ FollowUndervalued by 176% based on the discounted cash flow analysis.
| Market cap | $7.31 Billion |
|---|---|
| Enterprise Value | $7.42 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.25 |
| Beta | 1 |
| Outstanding Shares | 254,806,000 |
| P/E Ratio | 136.1 |
|---|---|
| PEG | -214.24 |
| Price to Sales | 2.56 |
| Price to Book Ratio | 2.56 |
| Enterprise Value to Revenue | 2.43 |
| Enterprise Value to EBIT | 42.29 |
| Enterprise Value to Net Income | 103 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.62 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 58.06% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.03%▼ 65.83% |
|---|---|
| Total Invested | $2.38M▼ 99.95% |
| Investors Holding | 11▼ 588.00% |
No data
Celsius Holdings, Inc., is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness drink and a pioneer in the rapidly growing performance energy sector, CEL...